JOINDER AGREEMENT AND FIRST AMENDMENT TO ASSET PURCHASE AGREEMENTAsset Purchase Agreement • September 17th, 2013 • Pernix Therapeutics Holdings, Inc. • Pharmaceutical preparations • New York
This JOINDER AGREEMENT AND FIRST AMENDMENT TO ASSET PURCHASE AGREEMENT (this “Amendment”) is made and entered into as of September 11, 2013, (the “Amendment Date”), by and among Breckenridge Pharmaceutical, Inc., a Florida corporation (“Purchaser”), and Pernix Therapeutics Holding, Inc., a Maryland company (“Pernix”), Cypress Pharmaceuticals, Inc., a Mississippi company (“Cypress”) (Pernix and Cypress being referred to collectively as “Seller”) and Macoven Pharmaceuticals, LLC, a Louisiana limited liability company (“Macoven”). Purchaser, Seller and Macoven are each referred to individually as a “Party” and together as the “Parties.”
